Autopsy report · NCT02157545
The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine
Cause of deathSlow enrollment, also regulatory or ethics
“No eligible subjects identified. Study closed with IRB.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Shashi Bhatt, MD
- Sponsor type
- University, hospital or other
- Conditions
- Muscle Relaxants
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Calm for Cancer Patients Receiving Chemotherapy
“Study was never submitted to the IRB so never received permission to or enrolled any subjects” - Methadone as an Alternative Treatment for Children Underdoing HSCT
“Study is closed with the IRB due to no funding. May resume once funding is obtained.” - Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy
“Study never approved by the IRB. Was not initiated” - Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
“Study did not receive IRB approval, so did not start” - Suprainguinal Fascia Iliaca Compartment Block in Direct Anterior Approach to Total Hip Arthroplasty
“Study never approved by IRB or initiated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.